Celcuity wins approval for breast cancer drug Revtorpyk

July 14, 2026 04:43 PM EDT PharmaFDA+ Cel­cu­ity wins ap­proval for breast can­cer drug Revtor­pyk Nicole DeFeudis Senior Reporter A small pub­lic biotech won ap­proval for a breast can­cer drug that was de­signed to im­prove on sim­i­lar treat­ments from No­var­tis and Roche. The FDA … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER